73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu
Digital rectal examination is not useful to early detect prostate cancers, says new research

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have
Researchers uncover how breast cancer cells become resistant to therapy

Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res

Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it
Healthy gut bacteria can help fight cancer in other parts of the body, researchers find

Healthy gut bacteria can help fight cancer in other parts of the body, researchers find

by UT Southwestern Medical CenterImmune checkpoint therapy (ICT) helps gut microbiota travel from the gut to the lymph nodes where they activate immune cells (dendritic cells and T cells). Ultima

Healthy gut bacteria can help fight cancer in other parts of the body, researchers find

by UT Southwestern Medical CenterImmune checkpoint therapy (ICT) helps gut microbiota travel from the gut to the lymph nodes where they activate immune cells (dendritic cells and T cells). Ultima
First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of
Scientists find core regulatory circuit controlling identity of aggressive leukemia

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee
Study explores why patients skip appointments for suspected cancer

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect
Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch
Moderate delays safe in treating colon cancer

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect
Automated, accurate reporting for NGS-based clonality testing

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot
Pancreatic tumors may require a one-two-three punch

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s